PTPN22 and neoplasm: Earlier examples of such peptides include the tumour-penetrating peptides iRGD and LyP-1; iRGD has an inherent anti-metastatic activity28 and LyP-1 elicits apoptosis in tumour cells and tumour macrophages29,30.